Clear Harbor Asset Management, LLC Kymera Therapeutics, Inc. Transaction History
Clear Harbor Asset Management, LLC
- $1.3 Billion
- Q2 2025
A detailed history of Clear Harbor Asset Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 11,194 shares of KYMR stock, worth $502,610. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,194
Previous 10,356
8.09%
Holding current value
$502,610
Previous $283,000
72.44%
% of portfolio
0.04%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding KYMR
# of Institutions
180Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$301 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$290 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$269 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$269 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$235 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.46B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...